Monoclonal Gammopathy of Undetermined Significance (MGUS) Latest Advances
Find the Latest Research About Monoclonal Gammopathy of Undetermined Significance (MGUS)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2586 publications
Machine Learning for Monoclonal Gammopathy of Undetermined Significance Screening: Who, How, and Why?
Journal: JCO clinical cancer informatics
Published: June 22, 2026
Site-Specific Profiling of Monoclonal IgG N-Glycosylation Reveals Dynamic Sialylation Changes Associated with Multiple Myeloma.
Journal: Journal of proteome research
Published: June 01, 2026
Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.
Journal: Journal of the peripheral nervous system : JPNS
Published: May 25, 2026
Machine Learning Model Predicts Monoclonal Gammopathy Using Routine Laboratory Values.
Journal: JCO clinical cancer informatics
Published: May 21, 2026
Multiple myeloma with atypical gammopathy: a rare case report
Journal: Annales de biologie clinique
Published: May 09, 2026
Renal presentation of diffuse large B-cell lymphoma emerging after pre-existing IgG4-related disease and monoclonal gammopathy of undetermined significance.
Journal: BMJ case reports
Published: May 08, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.
Journal: Clinical and experimental rheumatology
Published: May 07, 2026
Performance and additional benefits of MALDI-TOF-MS in M-protein detection in plasma cell disorders.
Performance and additional benefits of MALDI-TOF-MS in M-protein detection in plasma cell disorders.
Journal: Annals of medicine
Published: April 28, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.
Journal: Research square
Published: April 27, 2026
Last Updated: 06/30/2026